India is moving towards amending a law to introduce provisions that will make it impossible for Indian pharmaceutical companies to produce generic versions of patented drugs. If it goes through we can say goodbye to cheap versions of expensive, sometimes life-saving, drugs produced by mncs.

The government wants to amend the Drugs and Cosmetics Act (dca), 1940, to introduce a clause on